Not exact matches
In a test of this theory, researchers have demonstrated that mice harboring a human SCN1A gene mutation that results in Dravet
Syndrome (DS), a severe and intractable
genetic epilepsy, have electrical disturbances in the heart that culminate in ventricular fibrillation and sudden cardiac death.
Scientists used CRISPR - Cas9 to shed light on why people with 15q13.3 microdeletion
syndrome — a rare human
genetic disorder — are more likely to develop brain disorders like autism spectrum disorder,
epilepsy and schizophrenia (Karun K. Singh, abstract 103.05, see attached summary).
Using a novel combination of technologies, including trio exome sequencing of patient / parental DNA and
genetic studies in the tiny larvae of zebrafish, the EuroEPINOMICS RES consortium found that mutations in the gene CHD2 are responsible for a subset of
epilepsy patients with symptoms similar to Dravet
syndrome — a severe form of childhood
epilepsy that is in many patients resistant to currently available anti-epileptic drugs.
Importantly, the development of a new animal model for Dravet
syndrome based on reduced CHD2 expression might help to find effective treatments that could improve the lives of thousands of people suffering from Dravet
syndrome and perhaps other
genetic epilepsies.»
Dravet
syndrome is one of the most challenging forms of childhood
epilepsy, resulting from a specific
genetic mutation that affects sodium channels in the brain.
Altered intrathalamic GABAA neurotransmission in a mouse model of a human
genetic absence
epilepsy syndrome.
Altered cortical GABAA receptor composition, physiology, and endocytosis in a mouse model of a human
genetic absence
epilepsy syndrome.
The stem cells actually started out as skin cells donated by patients with Dravet
syndrome, a severe form of childhood
epilepsy — so they carry the
genetic defect that causes that disease.
For the trial, researchers enrolled 120 children from 2 to 18 years old with Dravet
syndrome, a rare
genetic form of
epilepsy that kills up to 20 percent of patients by the time they are 20.
We describe a distinct SCN1A phenotype, early infantile SCN1A encephalopathy, which is readily distinguishable from the well - recognized entities of Dravet
syndrome and
genetic epilepsy with febrile seizures plus.
For example, a study conducted in his own lab found that forebrain assembloids generated from patients with Timothy
syndrome — a
genetic disease associated with autism and
epilepsy, showed abnormal migration of GABAergic neurons during the development of the cerebral cortex.
Inclusion criteria for the current study were: European Caucasian descent, IQ ≥ 80, no diagnosis of conduct disorder, autism, anxiety disorder, depression,
epilepsy, general learning difficulties, neurological disorders or known
genetic disorders (e.g. Fragile X
syndrome, Down
syndrome).